JP2020143081A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020143081A5 JP2020143081A5 JP2020080282A JP2020080282A JP2020143081A5 JP 2020143081 A5 JP2020143081 A5 JP 2020143081A5 JP 2020080282 A JP2020080282 A JP 2020080282A JP 2020080282 A JP2020080282 A JP 2020080282A JP 2020143081 A5 JP2020143081 A5 JP 2020143081A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- acceptable salt
- pharmaceutically acceptable
- protecting groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 36
- 125000006239 protecting group Chemical group 0.000 claims 30
- 150000003839 salts Chemical class 0.000 claims 24
- 238000000034 method Methods 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 4
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 4
- -1 1-methyl-1H-pyrazole-4-yl Chemical group 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 239000012351 deprotecting agent Substances 0.000 claims 1
- 230000022244 formylation Effects 0.000 claims 1
- 238000006170 formylation reaction Methods 0.000 claims 1
- 0 *[C@@](CCCC1)[C@@]1N Chemical compound *[C@@](CCCC1)[C@@]1N 0.000 description 20
- BECXWGINFVUKDI-UHFFFAOYSA-N O=C(c1c(nc2F)Cl)NCc1c2F Chemical compound O=C(c1c(nc2F)Cl)NCc1c2F BECXWGINFVUKDI-UHFFFAOYSA-N 0.000 description 3
- UCNGGGYMLHAMJG-UHFFFAOYSA-N CC1(C)OB(c2c[n](C)nc2)OC1(C)C Chemical compound CC1(C)OB(c2c[n](C)nc2)OC1(C)C UCNGGGYMLHAMJG-UHFFFAOYSA-N 0.000 description 2
- PBNKENFXRLNYCJ-UHFFFAOYSA-N CC1(C)OS(c2c[n](C)nc2)OC1(C)C Chemical compound CC1(C)OS(c2c[n](C)nc2)OC1(C)C PBNKENFXRLNYCJ-UHFFFAOYSA-N 0.000 description 1
- JBLHYAFLUQSWOF-UHFFFAOYSA-N NC(c(c(Cl)n1)cc(F)c1F)=O Chemical compound NC(c(c(Cl)n1)cc(F)c1F)=O JBLHYAFLUQSWOF-UHFFFAOYSA-N 0.000 description 1
- OJKXBPMNEIRBIC-UHFFFAOYSA-N OC(c(c1c(nc2F)Cl)c2F)NC1=O Chemical compound OC(c(c1c(nc2F)Cl)c2F)NC1=O OJKXBPMNEIRBIC-UHFFFAOYSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021180105A JP2022017477A (ja) | 2014-12-18 | 2021-11-04 | 縮合複素芳香族ピロリジノンの固体状態形態 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462093564P | 2014-12-18 | 2014-12-18 | |
| US62/093,564 | 2014-12-18 | ||
| US201562115223P | 2015-02-12 | 2015-02-12 | |
| US62/115,223 | 2015-02-12 | ||
| US201562180222P | 2015-06-16 | 2015-06-16 | |
| US62/180,222 | 2015-06-16 | ||
| JP2017532678A JP6778195B2 (ja) | 2014-12-18 | 2015-12-17 | 縮合複素芳香族ピロリジノンの固体状態形態 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017532678A Division JP6778195B2 (ja) | 2014-12-18 | 2015-12-17 | 縮合複素芳香族ピロリジノンの固体状態形態 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021180105A Division JP2022017477A (ja) | 2014-12-18 | 2021-11-04 | 縮合複素芳香族ピロリジノンの固体状態形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020143081A JP2020143081A (ja) | 2020-09-10 |
| JP2020143081A5 true JP2020143081A5 (https=) | 2020-11-26 |
| JP6974534B2 JP6974534B2 (ja) | 2021-12-01 |
Family
ID=55299676
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017532678A Active JP6778195B2 (ja) | 2014-12-18 | 2015-12-17 | 縮合複素芳香族ピロリジノンの固体状態形態 |
| JP2020080282A Active JP6974534B2 (ja) | 2014-12-18 | 2020-04-30 | 縮合複素芳香族ピロリジノンの固体状態形態 |
| JP2021180105A Pending JP2022017477A (ja) | 2014-12-18 | 2021-11-04 | 縮合複素芳香族ピロリジノンの固体状態形態 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017532678A Active JP6778195B2 (ja) | 2014-12-18 | 2015-12-17 | 縮合複素芳香族ピロリジノンの固体状態形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021180105A Pending JP2022017477A (ja) | 2014-12-18 | 2021-11-04 | 縮合複素芳香族ピロリジノンの固体状態形態 |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US10676473B2 (https=) |
| EP (2) | EP3677582B1 (https=) |
| JP (3) | JP6778195B2 (https=) |
| KR (1) | KR102037502B1 (https=) |
| CN (1) | CN107108609B (https=) |
| AU (1) | AU2015365580B2 (https=) |
| BR (1) | BR112017013149B1 (https=) |
| CA (1) | CA2970864C (https=) |
| CL (1) | CL2017001561A1 (https=) |
| CO (1) | CO2017005910A2 (https=) |
| CR (1) | CR20170249A (https=) |
| DK (1) | DK3233857T3 (https=) |
| DO (1) | DOP2017000130A (https=) |
| EA (1) | EA032291B1 (https=) |
| EC (1) | ECSP17038100A (https=) |
| ES (1) | ES2788454T3 (https=) |
| GE (2) | GEAP201914545A (https=) |
| IL (1) | IL252941B (https=) |
| MX (1) | MX373586B (https=) |
| MY (1) | MY199935A (https=) |
| NZ (1) | NZ732371A (https=) |
| PE (1) | PE20171179A1 (https=) |
| PH (1) | PH12017501123A1 (https=) |
| PL (1) | PL3233857T3 (https=) |
| SG (1) | SG11201701911QA (https=) |
| TN (1) | TN2017000080A1 (https=) |
| UA (1) | UA120632C2 (https=) |
| WO (1) | WO2016097862A2 (https=) |
| ZA (1) | ZA201701800B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY199935A (en) * | 2014-12-18 | 2023-11-29 | Wells Therapeutics Inc | Solid state forms of fused heteroaromatic pyrrolidinones |
| WO2018013239A1 (en) * | 2016-07-13 | 2018-01-18 | Takeda Pharmaceutical Company Limited | Combination of spleen tyrosine kinase inhibitors and other therapeutic agents |
| CA3079292A1 (en) | 2017-10-19 | 2019-04-25 | Bayer Animal Health Gmbh | Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals |
| WO2019088039A1 (en) | 2017-10-30 | 2019-05-09 | Takeda Pharmaceutical Company Limited | Treatment of acute myeloid leukemia |
| MY208604A (en) * | 2018-12-14 | 2025-05-20 | Chia Tai Tianqing Pharmaceutical Group Co Ltd | Salt of syk inhibitor and crystalline form thereof |
| JP2022519383A (ja) | 2019-02-07 | 2022-03-23 | ヤンセン バイオテツク，インコーポレーテツド | ジヒドロオロト酸デヒドロゲナーゼ阻害剤 |
| TW202104207A (zh) | 2019-04-17 | 2021-02-01 | 美商健生生物科技公司 | 二氫乳清酸脫氫酶抑制劑 |
| WO2021070132A1 (en) | 2019-10-10 | 2021-04-15 | Janssen Biotech, Inc. | Bi-aryl dihydroorotate dehydrogenase inhibitors |
| JP7554829B2 (ja) | 2019-12-19 | 2024-09-20 | ヤンセン ファーマシューティカ エヌ．ベー． | 置換直鎖スピロ誘導体 |
| WO2022074534A1 (en) | 2020-10-05 | 2022-04-14 | Janssen Biotech, Inc. | Combinations of dihydroorotate dehydrogenase inhibitors and hypomethylating agents |
| WO2022127753A1 (zh) * | 2020-12-18 | 2022-06-23 | 山东轩竹医药科技有限公司 | 稠环类AhR抑制剂 |
| MX2023013436A (es) | 2021-05-11 | 2023-12-12 | Janssen Pharmaceutica Nv | Terapias de combinacion. |
| KR20240006631A (ko) | 2021-05-11 | 2024-01-15 | 얀센 파마슈티카 엔브이 | 조합 요법 |
| KR102539612B1 (ko) | 2021-12-24 | 2023-06-02 | 엘에스일렉트릭(주) | IP 기반 RAPIEnet을 지원하는 통신 디바이스 및 이를 포함하는 네트워크 시스템 |
| CN120322230A (zh) | 2022-11-30 | 2025-07-15 | 詹森药业有限公司 | 包含多发性内分泌癌蛋白-mll抑制剂和至少一种其他治疗剂的组合 |
| EP4626427A1 (en) | 2022-11-30 | 2025-10-08 | Janssen Pharmaceutica NV | Combinations comprising a menin-mll inhibitor and a bcl-2 inhibitor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5400388B2 (ja) * | 2005-12-15 | 2014-01-29 | ライジェル ファーマシューティカルズ， インコーポレイテッド | キナーゼインヒビターおよびその利用 |
| SG181857A1 (en) | 2009-12-23 | 2012-07-30 | Takeda Pharmaceutical | Fused heteroaromatic pyrrolidinones as syk inhibitors |
| JP6026525B2 (ja) * | 2011-06-22 | 2016-11-16 | 武田薬品工業株式会社 | 置換６−アザ−イソインドリン−１−オン誘導体 |
| TW201625263A (zh) * | 2014-09-24 | 2016-07-16 | 千禧製藥公司 | 利用ＰＩ３Ｋα抑制劑與紫杉烷之組合治療 |
| MY199935A (en) * | 2014-12-18 | 2023-11-29 | Wells Therapeutics Inc | Solid state forms of fused heteroaromatic pyrrolidinones |
-
2015
- 2015-12-17 MY MYPI2017702209A patent/MY199935A/en unknown
- 2015-12-17 PE PE2017000944A patent/PE20171179A1/es unknown
- 2015-12-17 US US14/973,180 patent/US10676473B2/en active Active
- 2015-12-17 EP EP20156863.1A patent/EP3677582B1/en active Active
- 2015-12-17 GE GEAP201914545A patent/GEAP201914545A/en unknown
- 2015-12-17 CA CA2970864A patent/CA2970864C/en active Active
- 2015-12-17 NZ NZ732371A patent/NZ732371A/en not_active IP Right Cessation
- 2015-12-17 MX MX2017007162A patent/MX373586B/es active IP Right Grant
- 2015-12-17 TN TN2017000080A patent/TN2017000080A1/en unknown
- 2015-12-17 PL PL15831150T patent/PL3233857T3/pl unknown
- 2015-12-17 UA UAA201707489A patent/UA120632C2/uk unknown
- 2015-12-17 EA EA201791369A patent/EA032291B1/ru unknown
- 2015-12-17 ES ES15831150T patent/ES2788454T3/es active Active
- 2015-12-17 GE GEAP201514545A patent/GEP20197050B/en unknown
- 2015-12-17 WO PCT/IB2015/002489 patent/WO2016097862A2/en not_active Ceased
- 2015-12-17 CN CN201580068971.2A patent/CN107108609B/zh active Active
- 2015-12-17 DK DK15831150.6T patent/DK3233857T3/da active
- 2015-12-17 EP EP15831150.6A patent/EP3233857B1/en active Active
- 2015-12-17 AU AU2015365580A patent/AU2015365580B2/en active Active
- 2015-12-17 SG SG11201701911QA patent/SG11201701911QA/en unknown
- 2015-12-17 CR CR20170249A patent/CR20170249A/es unknown
- 2015-12-17 JP JP2017532678A patent/JP6778195B2/ja active Active
- 2015-12-17 KR KR1020177019929A patent/KR102037502B1/ko active Active
- 2015-12-17 BR BR112017013149-8A patent/BR112017013149B1/pt not_active IP Right Cessation
-
2017
- 2017-03-13 ZA ZA2017/01800A patent/ZA201701800B/en unknown
- 2017-05-31 DO DO2017000130A patent/DOP2017000130A/es unknown
- 2017-06-15 CL CL2017001561A patent/CL2017001561A1/es unknown
- 2017-06-15 PH PH12017501123A patent/PH12017501123A1/en unknown
- 2017-06-15 CO CONC2017/0005910A patent/CO2017005910A2/es unknown
- 2017-06-15 IL IL252941A patent/IL252941B/en active IP Right Grant
- 2017-06-16 EC ECIEPI201738100A patent/ECSP17038100A/es unknown
-
2020
- 2020-04-30 JP JP2020080282A patent/JP6974534B2/ja active Active
- 2020-05-08 US US16/870,653 patent/US11352355B2/en active Active
-
2021
- 2021-11-04 JP JP2021180105A patent/JP2022017477A/ja active Pending
-
2022
- 2022-12-23 US US18/088,286 patent/US20230348461A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020143081A5 (https=) | ||
| JP2022043078A5 (https=) | ||
| TW200848018A (en) | A therapeutic medicine of influenza | |
| WO2017201846A1 (zh) | 一种噁唑烷酮类抗菌药物及其中间体的制备方法 | |
| JP2009542613A5 (https=) | ||
| TWI579259B (zh) | 製備（１ｒ，２ｓ）－２－（３，４－二氟苯基）－３－ｒ取代－環丙胺的方法 | |
| CN103333942A (zh) | 左旋吡喹酮的合成方法 | |
| JP2003525287A5 (ja) | １,３-ジヒドロ-２ｈ-インドール-２-オンならびにアルギニン-バソプレッシンのｖ1bまたはｖ1bおよびｖ1aの両方のレセプターのリガンドとしてのそれらの使用 | |
| JP2025502931A (ja) | 薬物－リンカー複合体の調製方法 | |
| CN113087712B (zh) | L-氨基酸-6-胶霉毒素酯三氟乙酸盐及其制备方法 | |
| TWI746639B (zh) | 小蘗鹼型生物鹼之製造方法 | |
| CN102250101A (zh) | 二-α-喹啉-低聚乙二醇酞菁锌及其制备方法 | |
| JP2022116171A5 (https=) | ||
| CN105601535A (zh) | 一种用于金属有机框架的配体及其合成方法 | |
| JP7620091B2 (ja) | 縮合環ジイミド誘導体、その製造方法と使用 | |
| JP2018525406A (ja) | アリール化合物の合成 | |
| TWI548615B (zh) | 化合物、及其製造方法 | |
| CN112110897B (zh) | 一种氘代克里唑蒂尼及其衍生物的制备方法 | |
| CN113637003A (zh) | 一种制备2-氨基-6-（哌啶-4-酰基）吡啶衍生物的方法 | |
| CN114249723B (zh) | 一种唑吡坦及其关键中间体的制备方法 | |
| CN110372533B (zh) | 一种阳离子型线性氯胺抗菌剂及其合成方法 | |
| Xie et al. | Synthesis of Nitrogen Bridgehead Heterocycles with Phosphonates via a Novel Tandem Process | |
| JP2006514071A5 (https=) | ||
| CN111196839B (zh) | 一种硫链丝菌素衍生物及其制备方法 | |
| CN107973830B (zh) | 一种新奥霉素的全合成方法 |